Insider Trading & Ownership of Ph.D. Noubar B. Afeyan

Location
Cambridge, MA
Summary
The estimated net worth of Ph.D. Noubar B. Afeyan is at least $183,139,027 dollars as of 02 Mar 2026. Ph.D. Noubar B. Afeyan is the Director of Moderna, Inc. and owns shares of Moderna, Inc. (MRNA) stock worth about $183.14M.
Signature
/s/ Noubar B. Afeyan, Ph.D.
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Ph.D. Noubar B. Afeyan and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Ph.D. Noubar B. Afeyan has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $183,139,027.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Moderna, Inc. ($183,139,027).
  • Past-year value change for that position: -$703,306.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Ph.D. Noubar B. Afeyan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRNA Moderna, Inc. Director $183,139,027 -$703,306 -0.38% 11 Dec 2025
GENB Generate Biomedicines, Inc. Director, 10%+ Owner 26 Feb 2026
OMGA Omega Therapeutics, Inc. Director, 10%+ Owner 07 Jun 2023
RUBY Rubius Therapeutics, Inc. Director, 10%+ Owner 12 May 2022

Insider Transactions Reported by Ph.D. Noubar B. Afeyan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored